Involvement of Mesenchymal Stem Cells in Oral Mucosal Bacterial Immunotherapy.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2020
Historique:
received: 29 05 2020
accepted: 19 10 2020
entrez: 17 12 2020
pubmed: 18 12 2020
medline: 13 5 2021
Statut: epublish

Résumé

Recent clinical observations indicate that bacterial vaccines induce cross-protection against infections produced by different microorganisms. MV130, a polyvalent bacterial sublingual preparation designed to prevent recurrent respiratory infectious diseases, reduces the infection rate in patients with recurrent respiratory tract infections. On the other hand, mesenchymal stem cells (MSCs) are key cell components that contribute to the maintenance of tissue homeostasis and exert both immunostimulatory and immunosuppressive functions. Herein, we study the effects of MV130 in human MSC functionality as a potential mechanism that contributes to its clinical benefits. We provide evidence that during MV130 sublingual immunization of mice, resident oral mucosa MSCs can take up MV130 components and their numbers remain unchanged after vaccination, in contrast to granulocytes that are recruited from extramucosal tissues. MSCs treated

Identifiants

pubmed: 33329530
doi: 10.3389/fimmu.2020.567391
pmc: PMC7711618
doi:

Substances chimiques

Bacterial Vaccines 0
Cytokines 0
Receptors, Pattern Recognition 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

567391

Informations de copyright

Copyright © 2020 Vázquez, Fernández-Sevilla, Jiménez, Pérez-Cabrera, Yañez, Subiza, Varas, Valencia and Vicente.

Déclaration de conflit d'intérêts

JS is the CEO of Inmunotek SL, a pharmaceutical company that manufactures bacterial vaccines. The authors declare that this study received funding from Inmunotek SL. The funder had the following involvement in the study: final writing and editing of the manuscript.

Références

Stem Cells Int. 2017;2017:8085637
pubmed: 28740515
Front Microbiol. 2019 Jan 14;9:3225
pubmed: 30692968
Sci Rep. 2017 Jun 14;7(1):3484
pubmed: 28615711
Thorax. 2019 Jan;74(1):43-50
pubmed: 30076187
J Leukoc Biol. 2010 Nov;88(5):1005-15
pubmed: 20682625
Infect Dis Ther. 2020 Jun;9(2):275-290
pubmed: 32333286
Oral Dis. 2018 Mar;24(1-2):22-25
pubmed: 29480644
PLoS One. 2013 Dec 30;8(12):e82867
pubmed: 24386121
Mol Biol Cell. 2001 Jun;12(6):1737-49
pubmed: 11408581
Stem Cell Res Ther. 2019 Feb 13;10(1):58
pubmed: 30760316
Gut. 2009 Jul;58(7):929-39
pubmed: 19136511
Cell Immunol. 2018 Apr;326:60-67
pubmed: 28093098
FASEB J. 2014 Sep;28(9):3856-66
pubmed: 24830384
Chest. 2004 Nov;126(5):1645-55
pubmed: 15539739
Cell Rep. 2020 Feb 11;30(6):1923-1934.e4
pubmed: 32049021
Stem Cells Int. 2020 Feb 25;2020:1327405
pubmed: 32184830
Cell Mol Immunol. 2016 Nov;13(6):711-721
pubmed: 27818489
Front Immunol. 2018 Dec 17;9:2936
pubmed: 30619296
Curr Med Res Opin. 2020 Feb;36(2):301-327
pubmed: 31794332
J Crohns Colitis. 2020 Oct 5;14(10):1424-1435
pubmed: 32318720
Eur J Clin Microbiol Infect Dis. 2012 Jul;31(7):1637-45
pubmed: 22124536
Inflamm Res. 2018 Jun;67(6):467-477
pubmed: 29362849
Stem Cells. 2010 May;28(5):984-95
pubmed: 20474080
Mucosal Immunol. 2017 Jul;10(4):924-935
pubmed: 27966556
Nature. 2009 Apr 30;458(7242):1185-90
pubmed: 19322177
PLoS Biol. 2008 Nov 18;6(11):e280
pubmed: 19018661
Clin Exp Allergy. 2015 Mar;45(3):677-86
pubmed: 24773115
Nat Immunol. 2014 Nov;15(11):1009-16
pubmed: 25329189
Oral Dis. 2018 May;24(4):561-572
pubmed: 29197149
Stem Cells. 2010 Dec;28(12):2229-38
pubmed: 20945332
Curr Pharm Des. 2016;22(41):6283-6293
pubmed: 27573928
Tissue Eng Part A. 2009 Jul;15(7):1579-89
pubmed: 19061425
Vaccine. 2010 Jun 7;28(25):4175-80
pubmed: 20412876
Cell Stem Cell. 2013 Oct 3;13(4):392-402
pubmed: 24094322
Sci Rep. 2017 Mar 06;7:43844
pubmed: 28262817
Eur J Immunol. 2018 Jan;48(1):180-193
pubmed: 28799230
Front Immunol. 2019 Apr 03;10:694
pubmed: 31001285
Cell Microbiol. 2016 Mar;18(3):424-36
pubmed: 26350435
Cell Immunol. 2011;271(1):147-56
pubmed: 21757189
Immune Netw. 2017 Apr;17(2):89-102
pubmed: 28458620
Front Immunol. 2019 Jun 28;10:1434
pubmed: 31316504
Stem Cells. 2011 Oct;29(10):1549-58
pubmed: 21898680
Vaccine. 2010 Dec 10;29(1):34-44
pubmed: 20974308
J Immunol. 2009 May 15;182(10):5994-6002
pubmed: 19414750
Front Immunol. 2017 Mar 30;8:339
pubmed: 28424688
Front Med (Lausanne). 2014 Oct 30;1:41
pubmed: 25593914
Hum Vaccin Immunother. 2019;15(9):2150-2153
pubmed: 30779677
Front Immunol. 2012 Jul 02;3:182
pubmed: 22783256
Cell Immunol. 2017 May;315:1-10
pubmed: 28284487
Am J Respir Crit Care Med. 2013 Apr 1;187(7):751-60
pubmed: 23292883
Science. 2016 Apr 29;352(6285):544-5
pubmed: 27126037
J Immunol. 2004 Sep 15;173(6):3844-54
pubmed: 15356132
Chest. 2001 Dec;120(6):2021-34
pubmed: 11742937
J Immunol. 2009 Jun 1;182(11):6851-60
pubmed: 19454681
Transl Stroke Res. 2012 Jul;3(1):s125-s131
pubmed: 23259009
FASEB J. 2019 Mar;33(3):4203-4211
pubmed: 30521384
Clin Exp Immunol. 2011 Apr;164(1):100–7
pubmed: 21391984
Nat Med. 2009 Jan;15(1):42-9
pubmed: 19098906
Sci Rep. 2014 Apr 02;4:4565
pubmed: 24691433
Front Immunol. 2019 Dec 13;10:2759
pubmed: 31921102
Leukemia. 2011 Sep;25(9):1408-14
pubmed: 21617697
Blood. 2017 Jan 12;129(2):171-176
pubmed: 27799160
PLoS One. 2010 Apr 26;5(4):e10088
pubmed: 20436665
Stem Cell Rev Rep. 2015 Dec;11(6):826-40
pubmed: 26250539
Cell Mol Immunol. 2016 May;13(3):369-78
pubmed: 25942600
Thorax. 2012 Jun;67(6):533-9
pubmed: 22250097
Leukemia. 2011 Apr;25(4):648-54
pubmed: 21242993
Stem Cell Res Ther. 2017 Sep 29;8(1):208
pubmed: 28962641
Front Immunol. 2019 Jun 04;10:1191
pubmed: 31214172
Stem Cells. 2016 Jul;34(7):1909-21
pubmed: 27015881
Stem Cells Dev. 2011 Jun;20(6):1011-9
pubmed: 20846028
Mol Cell. 2011 Nov 4;44(3):424-36
pubmed: 22055188

Auteurs

Alberto Vázquez (A)

Department of Cell Biology, School of Medicine, Complutense University of Madrid, Madrid, Spain.

Lidia M Fernández-Sevilla (LM)

Department of Cell Biology, School of Medicine, Complutense University of Madrid, Madrid, Spain.
Instituto de Investigación Sanitaria, Hospital Clínico San Carlos, Madrid, Spain.

Eva Jiménez (E)

Department of Cell Biology, School of Medicine, Complutense University of Madrid, Madrid, Spain.
Instituto de Investigación Sanitaria, Hospital Clínico San Carlos, Madrid, Spain.

David Pérez-Cabrera (D)

Department of Cell Biology, School of Medicine, Complutense University of Madrid, Madrid, Spain.

Rosa Yañez (R)

Hematopoietic Innovative Therapies Division, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, Centro de Investigación Biomédica en Red de Enfermedades Raras, Instituto de Investigaciones Sanitarias de la Fundación Jiménez Díaz, Madrid, Spain.

Jose Luis Subiza (JL)

Inmunotek, Alcalá de Henares, Madrid, Spain.

Alberto Varas (A)

Department of Cell Biology, School of Medicine, Complutense University of Madrid, Madrid, Spain.
Instituto de Investigación Sanitaria, Hospital Clínico San Carlos, Madrid, Spain.

Jaris Valencia (J)

Department of Cell Biology, School of Medicine, Complutense University of Madrid, Madrid, Spain.
Instituto de Investigación Sanitaria, Hospital Clínico San Carlos, Madrid, Spain.

Angeles Vicente (A)

Department of Cell Biology, School of Medicine, Complutense University of Madrid, Madrid, Spain.
Instituto de Investigación Sanitaria, Hospital Clínico San Carlos, Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH